ANDREW GLATT: Open Payments
NPI 1487684924 · ARCATA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 14 payments from 8 companies in 2025. Trend: 2023 $1,706 · 2024 $1,637 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $174 |
| Lilly USA, LLC | 3 | $73 |
| PFIZER INC. | 1 | $30 |
| ABBVIE INC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
Products named: Ozempic, MOUNJARO, NURTEC ODT, VRAYLAR, REXULTI, RELISTOR, COLLAGENASE SANTYL, Fluad.
Industry payments across CA — which companies pay providers there.
